JP2019521179A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019521179A5 JP2019521179A5 JP2019515776A JP2019515776A JP2019521179A5 JP 2019521179 A5 JP2019521179 A5 JP 2019521179A5 JP 2019515776 A JP2019515776 A JP 2019515776A JP 2019515776 A JP2019515776 A JP 2019515776A JP 2019521179 A5 JP2019521179 A5 JP 2019521179A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- weight
- concentration
- asparaginase
- polyalkylene oxide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022030538A JP7857767B2 (ja) | 2016-06-01 | 2022-03-01 | ポリアルキレンオキシド－アスパラギナーゼの製剤ならびにその製造法および使用法 |
| JP2025181444A JP2026016612A (ja) | 2016-06-01 | 2025-10-28 | ポリアルキレンオキシド－アスパラギナーゼの製剤ならびにその製造法および使用法 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662344252P | 2016-06-01 | 2016-06-01 | |
| US201662344249P | 2016-06-01 | 2016-06-01 | |
| US201662344256P | 2016-06-01 | 2016-06-01 | |
| US62/344,249 | 2016-06-01 | ||
| US62/344,252 | 2016-06-01 | ||
| US62/344,256 | 2016-06-01 | ||
| PCT/US2017/035461 WO2018017190A2 (en) | 2016-06-01 | 2017-06-01 | Formulations of polyalkylene oxide-asparaginase and methods of making and using the same |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022030538A Division JP7857767B2 (ja) | 2016-06-01 | 2022-03-01 | ポリアルキレンオキシド－アスパラギナーゼの製剤ならびにその製造法および使用法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019521179A JP2019521179A (ja) | 2019-07-25 |
| JP2019521179A5 true JP2019521179A5 (enExample) | 2020-06-18 |
| JP7109427B2 JP7109427B2 (ja) | 2022-07-29 |
Family
ID=60992770
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019515776A Active JP7109427B2 (ja) | 2016-06-01 | 2017-06-01 | ポリアルキレンオキシド－アスパラギナーゼの製剤ならびにその製造法および使用法 |
| JP2022030538A Active JP7857767B2 (ja) | 2016-06-01 | 2022-03-01 | ポリアルキレンオキシド－アスパラギナーゼの製剤ならびにその製造法および使用法 |
| JP2025181444A Pending JP2026016612A (ja) | 2016-06-01 | 2025-10-28 | ポリアルキレンオキシド－アスパラギナーゼの製剤ならびにその製造法および使用法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022030538A Active JP7857767B2 (ja) | 2016-06-01 | 2022-03-01 | ポリアルキレンオキシド－アスパラギナーゼの製剤ならびにその製造法および使用法 |
| JP2025181444A Pending JP2026016612A (ja) | 2016-06-01 | 2025-10-28 | ポリアルキレンオキシド－アスパラギナーゼの製剤ならびにその製造法および使用法 |
Country Status (32)
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20200131231A1 (en) | 2017-02-17 | 2020-04-30 | Oxford University Innovation Limited | Cell penetrating peptides |
| GB201812980D0 (en) | 2018-08-09 | 2018-09-26 | Univ Oxford Innovation Ltd | Cell-penetrating peptides |
| GB201812972D0 (en) | 2018-08-09 | 2018-09-26 | Univ Oxford Innovation Ltd | Cell-penetrating peptides |
| WO2020089743A1 (en) | 2018-11-02 | 2020-05-07 | Cadila Healthcare Limited | Pharmaceutical composition of pegylated l-asparaginase |
| US12465646B2 (en) * | 2018-12-07 | 2025-11-11 | Oxford University Innovation Limited | Linkers |
| JP2022514942A (ja) * | 2018-12-24 | 2022-02-16 | ジェノバ バイオファーマスーティカルズ リミテッド | ペグアスパラガーゼの凍結乾燥組成物 |
| AU2022256071A1 (en) * | 2021-04-06 | 2023-10-19 | Jazz Pharmaceuticals Ireland Ltd. | Formulations of l-asparaginase |
| CN114392237B (zh) * | 2021-12-28 | 2024-02-02 | 上海允英生物医药科技有限公司 | 一种冻干病毒制剂及其制备方法 |
| CN119326875A (zh) * | 2024-12-23 | 2025-01-21 | 中国人民解放军总医院第三医学中心 | L-ASNase在制备治疗膀胱癌药物中的应用及试剂盒 |
Family Cites Families (64)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
| DE2433883C2 (de) * | 1973-07-20 | 1986-03-27 | Research Corp., New York, N.Y. | Verwendung von physiologisch aktiven Polypeptiden |
| EP0083439B1 (de) * | 1981-12-31 | 1989-07-26 | ASTA Pharma AG | 4-Sulfido-oxazaphosphorine und deren Verwendung bei der Krebsbekämpfung und zur Immunsuppression |
| JPS58183626A (ja) | 1982-04-21 | 1983-10-26 | Nippon Oil Co Ltd | 白血病治療用ｌ−アスパラギナ−ゼ固定化剤 |
| US4729957A (en) | 1984-12-13 | 1988-03-08 | The United States Of America As Represented By The Department Of Health And Human Services | Process for manufacture of L-asparaginase from erwinia chrysanthemi |
| US5122614A (en) | 1989-04-19 | 1992-06-16 | Enzon, Inc. | Active carbonates of polyalkylene oxides for modification of polypeptides |
| US5324844A (en) | 1989-04-19 | 1994-06-28 | Enzon, Inc. | Active carbonates of polyalkylene oxides for modification of polypeptides |
| ES2136595T5 (es) * | 1989-04-19 | 2004-04-01 | Enzon, Inc. | Carbonatos activos de oxidos de polialquileno para la modificacion de polipeptidos. |
| GB9017002D0 (en) | 1990-08-02 | 1990-09-19 | Health Lab Service Board | Improved method for the purification of erwina l-asparaginase |
| US5618710A (en) * | 1990-08-03 | 1997-04-08 | Vertex Pharmaceuticals, Inc. | Crosslinked enzyme crystals |
| TW197439B (enExample) | 1991-04-04 | 1993-01-01 | Ueno Pharmaceutics Applic Res Co Ltd | |
| US5283253A (en) | 1991-09-23 | 1994-02-01 | Florida State University | Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them |
| AU3140093A (en) | 1991-11-22 | 1993-06-15 | University Of Mississippi, The | Synthesis and optical resolution of the taxol side chain and related compounds |
| US5200534A (en) | 1992-03-13 | 1993-04-06 | University Of Florida | Process for the preparation of taxol and 10-deacetyltaxol |
| JPH08500973A (ja) | 1992-05-21 | 1996-02-06 | ザ ペン ステイト リサーチ ファウンデーション | タキソール、関連タキサン及び他の新規な抗癌／抗ウイルス性化合物原料としてのイチイ培養組織 |
| US5274137A (en) | 1992-06-23 | 1993-12-28 | Nicolaou K C | Intermediates for preparation of taxols |
| US5294637A (en) | 1992-07-01 | 1994-03-15 | Bristol-Myers Squibb Company | Fluoro taxols |
| US5202448A (en) | 1992-08-14 | 1993-04-13 | Napro Biotherapeutics, Inc. | Processes of converting taxanes into baccatin III |
| CA2100808A1 (en) | 1992-10-01 | 1994-04-02 | Vittorio Farina | Deoxy paclitaxels |
| FR2696462B1 (fr) | 1992-10-05 | 1994-11-25 | Rhone Poulenc Rorer Sa | Procédé d'obtention de la désacétyl-10 baccatine III. |
| FR2696461B1 (fr) | 1992-10-05 | 1994-11-10 | Rhone Poulenc Rorer Sa | Nouveaux dérivés d'analogues du taxol, leur préparation et les compositions qui les contiennent. |
| FR2696463B1 (fr) | 1992-10-05 | 1994-11-25 | Rhone Poulenc Rorer Sa | Procédé d'obtention de la désacétyl-10 baccatine III. |
| FR2696458B1 (fr) | 1992-10-05 | 1994-11-10 | Rhone Poulenc Rorer Sa | Procédé de préparation de dérivés du taxane. |
| FR2696464B1 (fr) | 1992-10-05 | 1994-11-10 | Rhone Poulenc Rorer Sa | Nouveau procédé d'estérification de la baccatine III et de la désacétyl-10 baccatine III. |
| US5279949A (en) | 1992-12-07 | 1994-01-18 | Board Of Trustees Operating Michigan State University | Process for the isolation and purification of taxol and taxanes from Taxus spp |
| US6277828B1 (en) * | 1993-08-20 | 2001-08-21 | Syntex (U.S.A.) Inc. | Pharmaceutical formulations of nerve growth factor |
| US5824701A (en) | 1993-10-20 | 1998-10-20 | Enzon, Inc. | Taxane-based prodrugs |
| US5415869A (en) | 1993-11-12 | 1995-05-16 | The Research Foundation Of State University Of New York | Taxol formulation |
| US5599902A (en) | 1994-11-10 | 1997-02-04 | Arizona Board Of Regents Acting On Behalf Of Arizona State University | Cancer inhibitory peptides |
| US6087151A (en) | 1995-02-08 | 2000-07-11 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | DNA coding for mammalian L-asparaginase |
| CN1113066C (zh) | 1995-04-21 | 2003-07-02 | 帝国脏器制药株式会社 | 新型肽衍生物 |
| CA2226575C (en) | 1995-07-27 | 2011-10-18 | Genentech, Inc. | Stabile isotonic lyophilized protein formulation |
| US6537547B1 (en) | 1996-06-07 | 2003-03-25 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Polypeptides having L-asparaginase activity |
| US5821263A (en) | 1996-08-26 | 1998-10-13 | Bristol-Myers Squibb Company | Sulfenamide taxane derivatives |
| AU739028B2 (en) | 1996-09-27 | 2001-10-04 | Bristol-Myers Squibb Company | Hydrolyzable prodrugs for delivery of anticancer drugs to metastatic cells |
| WO1998022451A1 (en) | 1996-11-19 | 1998-05-28 | Daiichi Pharmaceutical Co., Ltd. | Taxol derivatives |
| US5977386A (en) | 1996-12-24 | 1999-11-02 | Bristol-Myers Squibb Company | 6-thio-substituted paclitaxels |
| ZA983496B (en) * | 1997-04-28 | 1999-10-25 | Lilly Co Eli | Methods for processing activated protein C. |
| US6991788B1 (en) | 1997-06-09 | 2006-01-31 | Childrens Hospital Los Angeles | Utilization of wolinella succinogenes asparaginase to treat diseases associated with asparagine dependence |
| DE69823501T2 (de) | 1997-06-09 | 2005-04-07 | Childrens Hospital Of Los Angeles, Los Angeles | Verwendung von wolinella succinogenes asparaginase zur behandlung von asparagin-abhängiger krankheiten |
| SK182599A3 (en) | 1997-06-20 | 2000-07-11 | Baker Norton Pharma | Soluble prodrugs of paclitaxel |
| US7288665B1 (en) | 1997-08-18 | 2007-10-30 | Florida State University | Process for selective derivatization of taxanes |
| US5854051A (en) | 1997-09-15 | 1998-12-29 | Heska Corporation | Parasitic helminth asparaginase proteins, nucleic acid molecules, and uses thereof |
| JPH1192468A (ja) | 1997-09-17 | 1999-04-06 | Yakult Honsha Co Ltd | 新規なタキサン誘導体 |
| JP4153660B2 (ja) | 1997-10-08 | 2008-09-24 | 株式会社横浜国際バイオ研究所 | タキソイド誘導体およびその製造方法 |
| US6180095B1 (en) | 1997-12-17 | 2001-01-30 | Enzon, Inc. | Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents |
| JP3643034B2 (ja) | 1998-03-26 | 2005-04-27 | シェーリング コーポレイション | ＰＥＧ−インターフェロンα結合体の保護のための処方物 |
| CA2634663C (en) | 1999-02-22 | 2009-08-25 | University Of Connecticut | Novel albumin-free factor viii formulations |
| US6323315B1 (en) | 1999-09-10 | 2001-11-27 | Basf Aktiengesellschaft | Dolastatin peptides |
| US20020065397A1 (en) | 2000-10-12 | 2002-05-30 | Joseph Roberts | Protecting therapeutic compositions from host-mediated inactivation |
| US20050143283A1 (en) | 2002-03-08 | 2005-06-30 | Eli Lilly And Company | Activated protein c formulations |
| EP1391213A1 (en) | 2002-08-21 | 2004-02-25 | Boehringer Ingelheim International GmbH | Compositions and methods for treating cancer using maytansinoid CD44 antibody immunoconjugates and chemotherapeutic agents |
| AU2004204136B2 (en) | 2003-01-06 | 2008-10-09 | Nektar Therapeutics | Thiol-selective water-soluble polmer derivatives |
| NZ572519A (en) | 2006-06-30 | 2011-06-30 | Defiante Farmaceutica Sa | Recombinant host for producing l-asparaginase ii |
| US20080260820A1 (en) * | 2007-04-19 | 2008-10-23 | Gilles Borrelly | Oral dosage formulations of protease-resistant polypeptides |
| US8617868B2 (en) | 2007-04-20 | 2013-12-31 | Dsm Ip Assets B.V. | Asparaginase enzyme variants and uses thereof |
| FI20070455A0 (fi) | 2007-06-08 | 2007-06-08 | Reagena Ltd Oy | Menetelmä syöpäsairauksien tai tulehdussairauksien hoitoon |
| WO2011003633A1 (en) | 2009-07-06 | 2011-01-13 | Alize Pharma Ii | Pegylated l-asparaginase |
| AU2011270670B2 (en) | 2010-06-25 | 2017-01-12 | Takeda Pharmaceutical Company Limited | Methods and compositions for CNS delivery of arylsulfatase A |
| US9322008B2 (en) | 2010-09-01 | 2016-04-26 | Indian Institute Of Technology | Mutants of L-asparaginase |
| RU2441914C1 (ru) | 2010-10-06 | 2012-02-10 | Учреждение Российской академии медицинских наук Научно-исследовательский институт биомедицинской химии имени В.Н. Ореховича РАМН (ИБМХ РАМН) | Способ получения субстанции рекомбинантной l-аспарагиназы erwinia carotovora |
| CN102138909B (zh) * | 2010-12-30 | 2013-03-13 | 常州千红生化制药股份有限公司 | 门冬酰胺酶冻干粉针剂及其制备方法以及门冬酰胺酶溶解液 |
| EP2766478A4 (en) | 2011-10-10 | 2015-06-17 | Los Angeles Childrens Hospital | NEW ASPARAGINASE AND METHOD FOR THE TREATMENT OF DISEASES RELATED TO ASPARAGINE DEPENDENCE |
| CN102657852A (zh) * | 2012-05-22 | 2012-09-12 | 范铭琦 | 重组沃氏菌天门冬酰胺酶药物组合物及其制备法和应用 |
-
2017
- 2017-06-01 EP EP17831465.4A patent/EP3463308B2/en active Active
- 2017-06-01 SM SM20220049T patent/SMT202200049T1/it unknown
- 2017-06-01 KR KR1020187037768A patent/KR102473887B1/ko active Active
- 2017-06-01 SG SG11201810685WA patent/SG11201810685WA/en unknown
- 2017-06-01 IL IL263349A patent/IL263349B2/en unknown
- 2017-06-01 RU RU2018146395A patent/RU2758796C2/ru active
- 2017-06-01 IL IL312621A patent/IL312621A/en unknown
- 2017-06-01 RS RS20220190A patent/RS62979B2/sr unknown
- 2017-06-01 PT PT178314654T patent/PT3463308T/pt unknown
- 2017-06-01 EP EP21211264.3A patent/EP4019007A1/en active Pending
- 2017-06-01 JP JP2019515776A patent/JP7109427B2/ja active Active
- 2017-06-01 FI FIEP17831465.4T patent/FI3463308T4/fi active
- 2017-06-01 US US16/306,302 patent/US12343387B2/en active Active
- 2017-06-01 SI SI201731078T patent/SI3463308T2/sl unknown
- 2017-06-01 MY MYPI2018002252A patent/MY198474A/en unknown
- 2017-06-01 AU AU2017299374A patent/AU2017299374B2/en active Active
- 2017-06-01 HR HRP20212027TT patent/HRP20212027T4/hr unknown
- 2017-06-01 ES ES17831465T patent/ES2905874T3/es active Active
- 2017-06-01 BR BR112018074823-4A patent/BR112018074823B1/pt active IP Right Grant
- 2017-06-01 PL PL17831465.4T patent/PL3463308T5/pl unknown
- 2017-06-01 KR KR1020237039742A patent/KR20230162139A/ko not_active Ceased
- 2017-06-01 MX MX2018014916A patent/MX388814B/es unknown
- 2017-06-01 LT LTEPPCT/US2017/035461T patent/LT3463308T/lt unknown
- 2017-06-01 HU HUE17831465A patent/HUE057856T2/hu unknown
- 2017-06-01 KR KR1020227042041A patent/KR102783452B1/ko active Active
- 2017-06-01 CN CN201780046796.6A patent/CN109640961B/zh active Active
- 2017-06-01 WO PCT/US2017/035461 patent/WO2018017190A2/en not_active Ceased
- 2017-06-01 DK DK17831465.4T patent/DK3463308T4/da active
- 2017-06-01 UA UAA201812981A patent/UA123020C2/uk unknown
- 2017-06-01 CA CA3026070A patent/CA3026070A1/en active Pending
-
2018
- 2018-11-23 ZA ZA2018/07943A patent/ZA201807943B/en unknown
- 2018-11-29 SA SA518400557A patent/SA518400557B1/ar unknown
- 2018-11-29 PH PH12018502540A patent/PH12018502540A1/en unknown
- 2018-11-30 CL CL2018003418A patent/CL2018003418A1/es unknown
- 2018-11-30 MX MX2021015544A patent/MX2021015544A/es unknown
- 2018-12-18 CO CONC2018/0013753A patent/CO2018013753A2/es unknown
-
2022
- 2022-02-08 CY CY20221100106T patent/CY1124980T1/el unknown
- 2022-02-23 ZA ZA2022/02259A patent/ZA202202259B/en unknown
- 2022-03-01 JP JP2022030538A patent/JP7857767B2/ja active Active
-
2023
- 2023-12-12 US US18/537,002 patent/US20240108701A1/en active Pending
-
2025
- 2025-01-17 US US19/029,699 patent/US20250242004A1/en active Pending
- 2025-10-28 JP JP2025181444A patent/JP2026016612A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2018146395A (ru) | Препараты полиалкиленоксид-аспарагиназы и способы их получения и применение | |
| JP2022071060A5 (enExample) | ||
| RU2010114042A (ru) | Применение пептида в качестве терапевтического средства | |
| RU2010113969A (ru) | Применение trp-6-трипторелина и d-leu6-лейпролида в качестве терапевтических средств | |
| JP2009531275A5 (enExample) | ||
| US10806783B2 (en) | Vaccine compositions | |
| RU2010114051A (ru) | Применение grf-1(1-29) и кортиколиберина в качестве терапевтических средств | |
| Lueth et al. | Nanotherapeutic provides dose sparing and improved antimicrobial activity against Brucella melitensis infections | |
| RU2010113986A (ru) | Применение пептида в качестве терапевтического средства | |
| US20230051846A1 (en) | Composition Comprising PIC For Treatment Of Cancer | |
| EP2119451A1 (en) | Lyophilized preparation comprising influenza vaccine, and method for preparation thereof | |
| JP5179521B2 (ja) | ペグ‐インターフェロンアルファ接合体および凍結保護剤としてラフィノースを含む組成物 | |
| Kouroussis et al. | Front-line treatment of metastatic breast cancer with docetaxel and epirubicin: A multicenter dose-escalation study | |
| JP2014504613A5 (enExample) | ||
| Yuning et al. | Research Progress of Natural Saccharides and Their Derivatives as Drug Delivery Materials | |
| CN101732705A (zh) | 用于治疗烈性肠道传染病的含霍乱毒素疫苗的制剂 | |
| NZ749069B2 (en) | Formulations of polyalkylene oxide-asparaginase and methods of making and using the same | |
| NZ788906B2 (en) | Formulations of polyalkylene oxide-asparaginase and methods of making and using the same | |
| CN114948944A (zh) | 含有硫酸舒欣啶和胺碘酮的组合物在制备治疗心律失常药物中的应用 | |
| RU2024125372A (ru) | Фармацевтические композиции для лечения недостаточности кислой сфингомиелиназы | |
| Pavlovsky et al. | Management of acute leukaemias | |
| CHEN et al. | The efficacy and safety of liver decanoic sulfonic sodium in the treatment of elderly patients with acute coronary syndrome | |
| CN108066290A (zh) | 一种真空发泡工艺制备甘草多糖冻干粉的方法 | |
| Manal M et al. | Vinorelbine, 5 fluorouracil and folinic acid [fufol-nav] versus paclitaxel [p] as first line treatment in metastatic breast cancer patients pre-treated with anthracycline | |
| Wasan et al. | Response to Banaszkiewicz and Radzikowski |